| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bcb35225a578542c5592310a91d18f18 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-675
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-5728
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-675
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-572
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18 |
| filingDate |
2007-09-28^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ae7db3e46e656f53738cf355646fc75
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_713197c2163b6386fe90e83bf6b78f50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c8d4ffa5bb6cdc55b10d3a1a884e872
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca0a0247f20e584938acb55316c133f3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e190a3876cc2a11696b390f0a4c71483 |
| publicationDate |
2012-03-30^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EA-016267-B1 |
| titleOfInvention |
Enantiomeric pure phosphonyldol as HIV inhibitors |
| abstract |
The invention provides 3-phosphoindole compounds useful for treating infections caused by viruses of the Flaviviridae family, and in particular HLV infections. Also provided are pharmaceutical compositions containing 3-phosphoindole compounds alone or in combination with one or more other antiviral agents, methods for their preparation, and methods for preparing a medicament comprising these compounds. 3-phosphoindole compounds are compounds of formula (C) wherein R ″ and R ″ independently are C1-6alkyl or Salkenyl, each of which may optionally be independently substituted with CN or halogen; each of R and R independently represents hydrogen or halogen; R 1 is hydrogen, phenylsulfonyl or 4-methoxybenzyl and Y is O-C 1-6 alkyl and their pharmaceutically acceptable salts. |
| priorityDate |
2006-09-29^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |